CIK 0001971532 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Telomir Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TELO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- FL
- Entity type
- operating
- EIN
- 872606031
- Phone
- 786-396-6723
- Business address
- 100 SE 2ND ST, SUITE 2000 #1009, MIAMI, FL, 33131
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-3 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- DEFA14A Proxy Proxy Materials
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure
- DEF 14A Proxy Proxy Statement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 8-K Event Regulation FD disclosure
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Insider Changes in Ownership
Page 1 of 8 · 150 filings